To test in a more clinically relevant model, we constructed orthotopic HCC xenografts in mouse liver and examined the efficacy of locoregional delivery of anti‐GPC3 CAR‐T cells through portal vein (p.v.)injection. Here, GPC3 is linked to hepatocellular carcinoma.